Australia's most trusted
source of pharma news
Friday, 26 April 2024
Posted 27 October 2021 AM
Adelaide-based biotech Vaxine says it is "relying on crowd funding" to cover the hefty costs of filing an application to register its protein-based COVID-19 vaccine in Australia.
A GoFundMe page set up by the company's business manager, Sharen Pringle, called 'Bring Covax-19 Vaccine back to Australia' has already raised over $113,000 in six days since it was set up, surpassing a third of its $326,500 target.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.